Plasma levels of gastric biomarkers in patients after bariatric surgery: Biomarkers after bariatric surgery

Hepato-Gastroenterology

Volumn 60, Issue 128, 2013, Pages 2129-2132

  Sillakivi, Toomas ^a   Suumann, Jaanus ^a   Kirsimägi, Ülle ^a   Peetsalu, Ants ^a  

^a TARTU UNIVERSITY CLINICS   (Estonia)

Author keywords

Biomarkers; Diagnostic tests; Obesity; Stomach; Surgery

Indexed keywords

GASTRIN 17; IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN I; PEPSINOGEN II;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; HELICOBACTER PYLORI; HUMAN; LAPAROSCOPIC SURGERY; MALE; MIDDLE AGED; PHENOTYPE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROVOCATION TEST; REFERENCE VALUE; SLEEVE GASTRECTOMY; STOMACH ATROPHY; STOMACH BYPASS; STOMACH MUCOSA; SURGICAL PATIENT; WEIGHT REDUCTION;

ADULT; ANTIBODIES, BACTERIAL; BARIATRIC SURGERY; BIOLOGICAL MARKERS; FASTING; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GASTRINS; HELICOBACTER PYLORI; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; STOMACH; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893656904     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge13463     Document Type: Article

References (25)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295:1549-1555.
2. Peetsalu A, Tamm A, Härkönen M, et al.: The effect of vagotomy and antrectomy on serum pepsinogens I and II. Scand J Gastroenterol 1990; 25:455-461. (Pubitemid 20208208)
3. Aärimaa M, Härkönen M, Varis K, et al.: Serum group I pepsinogens during insulin and pentagastrin tests in unoperated and vagotomized duodenal ulcer patients. Scand J Gastroenterol 1987; 22:956-960. (Pubitemid 17152835)
4. Sipponen P, Valle J, Varis K, Kekki M, Ihamäki T, Siurala M: Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990; 25:513-519. (Pubitemid 20208216)
5. Sipponen P, Samloff IM, Saukkonen M, Varis K: Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy. Gut 1985; 26:1179-1182. (Pubitemid 16216261)
6. Varis K, Isokoski M: Screening of type A gastritis. Ann Clin Res 1981; 13:133-138. (Pubitemid 11065980)
7. Sundbom M, Mårdh E, Mårdh S, Ohrvall M, Gustavsson S: Reduction in serum pepsinogen I after Roux-en-Y gastric bypass. J Gastrointest Surg 2003; 7:529-535. (Pubitemid 36877195)
8. Sundbom M, Holdstock C, Engström BE, et al.: Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg 2007; 17:304-310. (Pubitemid 46659288)
9. Väänänen H, Vauhkonen M, Helske T, et al.: Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15:885-891. (Pubitemid 36904458)
10. Storskrubb T, Aro P, Ronkainen J, et al.: Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008; 43:1448-1455.
11. Iijima K, Abe Y, Kikuchi R, et al.: Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 2009; 15:853-859.
12. Agréus L, Kuipers EJ, Kupcinskas L, et al.: Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012; 47:136-147.
13. Kekki M, Samloff IM, Varis K, Ihamäki T: Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl 1991; 186:109-116.
14. Samloff IM, Varis K, Ihamäki T, Siurala M, Rotter JI: Serum pepsinogens I and II and gastric acid output: effect of gastritis. Prog Clin Biol Res 1985; 173:129-138.
15. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83:204-209. (Pubitemid 12121596)
16. Varis K, Sipponen P, Laxén F, et al.: Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol 2000; 35:950-956.
17. Sipponen P, Vauhkonen M, Helske T, Kaariainen I, Harkonen M: Low circulating levels of gastrin-17 in patients with Barrett's esophagus. World J Gastroenterol 2005; 11: 5988-5992. (Pubitemid 41749213)
18. Sipponen P, Graham DY: Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007; 42:2-10. (Pubitemid 46033039)
19. Sipponen P, Ranta P, Helske T, et al.: Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002; 37:785-791. (Pubitemid 34836814)
20. Fischer L, Hildebrandt C, Bruckner T, et al.: Excessive weight loss after sleeve gastrectomy : a systematic review. Obes Surg 2012; 22(5):721-731.
21. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M: Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996; 31:546-550. (Pubitemid 26196134)
22. Agréus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P: Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol 2009; 44:564-570.
23. Sipponen P, Härkönen M: Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand J Gastroenterol 2010; 45:133-138.
24. Sipponen P, Laxén F, Huotari K, Härkönen M: Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 2003; 38:1209-1216. (Pubitemid 38096077)
25. Salaspuro M: Acetaldehyde and gastric cancer. J Dig Dis 2011; 12:51-59.